Source Feed: The Globe and Mail
Author: Jennifer Yang
Publication Date: October 28, 2025 - 07:00
Excitement around Alzheimer’s treatment tempered by questions about efficacy, accessibility
October 28, 2025
Lecanemab is the first new treatment for Alzheimer’s disease to reach Canada in 20 years, and Health Canada’s recent authorization of the disease-modifying drug has understandably triggered hope and excitement.
But for some researchers and clinicians who treat the disease, the development also represents a complicated story – one where enthusiasm for a new and desperately needed drug is tempered by sobering realities around its efficacy, accessibility and impact on an already strained health care system.
Unpublished Newswire
A new global health report suggests that every year from 2020 to 2024 about 1,400 deaths in Canada were associated with wildfire smoke pollution as climate change takes an increasing toll on the country’s health. The Lancet Countdown on health and climate change, compiled by more than 100 experts worldwide, is considered one of the most comprehensive looks at the subject.
October 28, 2025 - 20:38 | Jordan Omstead | The Globe and Mail
Seven obstetricians and gynecologists have resigned from Royal Inland Hospital in Kamloops, B.C., while four psychiatrists have stepped down from Vernon Jubilee Hospital.
October 28, 2025 - 20:19 | Victoria Femia | Global News - Canada
A senior official working at the Canada Revenue Agency says the agency is looking to artificial intelligence and better training to help call centre agents provide more accurate answers to taxpayers.
October 28, 2025 - 20:00 | | CBC News - Canada
Comments
Be the first to comment